Pharmacological management of migraine (SIGN)
This toolkit summarises the evidence-based recommendations in SIGN 155: Pharmacological management of patients with migraine.
For the full guideline see www.sign.ac.uk/our-guidelines/pharmacological-management-of-migraine/ (2026).
The guideline informs the Centre for Sustainability Neurology Pathway for Headache Headache | Right Decisions
Evidence-based recommendations are identified using an 
Recommended best practice based on the clinical experience of the guideline development group, are denoted by 
